We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
Information for healthcare professionals on how pulse oximeters are regulated, home use and issues to look out for when using the devices
The actions to take for sourcing medicines in different circumstances.
There are changes to the legislation of Reference Medicinal Products (RMPs) used to support abridged marketing authorisation applications
Guidance on how to complete your Electronic Application Form (eAF) and Cover Letter
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
The Innovative Devices Access Pathway (IDAP) pilot is designed to accelerate the development of innovative medical devices that meet an unmet clinical need in the NHS and support their integration into the UK market.
A step-by-step guide on using the MORE Platform for Registrations for Submissions of device related incidents.
Importing investigational medicinal products for use in clinical trials
Information about ensuring blood and blood component safety.
How to join the phase I accreditation scheme.
Submission dates and how the submissions using the EC decision reliance procedure work.
Reporting, investigating and recalling suspected defective medicinal products to the Defective Medicines Report Centre (DMRC).
Guidance on how to submit changes to labelling and patient information leaflets to MHRA.
Guidelines to help mitigate and manage medicine shortages.
Register as a manufacturer, importer or distributor of active substances.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Information for patients, healthcare professionals and developers of new medicines
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).